Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration

Kidney International

Volumn 66, Issue 3, 2004, Pages 1248-1256

  Wang, Minghui ^b   Liu, Shanying ^b   Ouyang, Nengtai ^b   Song, Erwei ^b   Lutz, Jens ^b   Heemann, Uwe ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Apoptosis; Chronic rejection; FTY720; Kidney transplantation; Lymphocyte infiltration

Indexed keywords

CYCLOSPORIN A; FINGOLIMOD; INTERLEUKIN 10; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC GRAFT REJECTION; DRUG EFFECT; FIBROGENESIS; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; TIME;

EID: 4344660143     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00878.x     Document Type: Article

References (57)

1. HOSTETTER TH: Chronic transplant rejection. Kidney Int 46:266-279, 1994
2. MULLER V, SZABO A, VIKLICKY O, et al: Sex hormones and gender-related differences: Their influences on chronic renal allograft rejection. Kidney Int 55:2011-2020, 1999
3. ALMOND PS, MATAS A, GILLINGHAM K, et al: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752-757, 1993
4. GAGNE K, BROUARD S, GIRAL M, et al: Highly altered Vβ repertoire of T cells infiltrating long-term rejected kidney allografts. J Immunol 164:1553-1563, 2000
5. KAMOUN M: Cellular and molecular parameters in human renal allograft rejection. Clin Biochem 34:29-34, 2000
6. MÜLLER V, HAMAR P, SZABO A, et al: In vivo migration of lymphocytes in chronically rejecting rat kidney allografts. Transplant Int 12:145-151, 1999
7. HEEMANN U, TULLIUS SG, TAMATAMI T, et al: Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts. Transplant Int 7:349-355, 1994
8. PAUL LC: Chronic allograft nephropathy: An update. Kidney Int 56:783-793, 1999
9. VALENTE JF, ALEXANDER WJ: Immunobiology of renal transplantation. Surg Clin North Am 78:1-26, 1998
10. WAAGA AM, GASSER M, KIST-VAN HOLTHE JE, et al: Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest 107:909-916, 2001
11. VELLA JP, SPADAFORA-FERREIRA M, MURPHY B, et al: Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 27:795-800, 1997
12. GUTTMANN RD, FORBES RD, ZHENG SX: The pathophysiology of chronic rejection. Am J Med Sci 313:302-304, 1997
13. SIBLEY RK: Morphologic features of chronic rejection in kidney and less commonly transplanted organs. Clin Transplant 8:293-298, 1994
14. OLIVE C, CHEUNG C, FALK MC: Apoptosis and expression of cytotoxic T lymphocyte effector molecules in renal allograft. Transplant Immunol 7:27-36, 1999
15. JEONG HJ, HONG SW, KIM YS, et al: Interstitial mononuclear cell infiltrates in chronic rejection of the kidney and correlation with peripheral blood. J Korean Med Sci 11:489-494, 1996
16. STREHLAU J, PAVLAKIS M, LIPMAN M, et al: The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 46:30-33, 1996
17. KIRK AD, IBRAHIM MA, BOLLINGER RR, et al: Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Transplantation 53:329-338, 1992
18. ADACHI K, KOHARA T, MISHINA T, FUJITA T: Design, synthesis, and structure activity relationship of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem 5:853-856, 1995
19. HONG JC, KAHAN BD: Immunosuppressive agents in organ transplantation: Past, present, and future. Semin Nephrol 20:108-125, 2000
20. YANAGAWA Y, HOSHINO Y, CHIBA K: The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival. Int J Immunopharmacol 22:597-602, 2000
21. YANAGAWA Y, SUGAHARA K, KATAOKA H, et al: FTY720, a novel immunosuppressant, induces sequestration circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival decreasing T cell infiltraiton into grafts but not cytokine production in vivo. J Immunol 160:5493-5496, 1998
22. OHBA M, LI XK, KITA Y, et al: Long-term graft acceptance in rat heart transplantation by gene transfection combined with FTY720 treatment. World J Surg 25:391-397, 2001
23. LI XK, TAMURA A, FUJINO M, et al: Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Clin Exp Immunol 123:331-339, 2000
24. FURUKAWA H, SUZUKI T, JIN MB, et al: Prolongation of canine liver allograft survival by a novel immuosuppressant, FTY720. Transplantation 69:235-241, 2000
25. BOHLER T, WAISER J, SCHUTZ M, et al: FTY720A mediates reduction of lynmphocyte counts in human renal allograft recipients by an apoptosis-independent mechanism. Transplant Int 13:S311-S313, 2000
26. UEDA H, TAKAHARA S, AZUMA H, et al: Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats. Eur Surg Res 32:279-283, 2000
27. OMURA T, SUZUKI T, SHIMAMURA T, et al: A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation. Transplant Proc 31:2783-2784, 1999
28. KOSHIBA T, JI P, TANAKA K, et al: Tolerance induction with FTY720 and donor-specific blood transfusion: Discrepancy between heart transplantation and intestinal transplantation. Transplant Proc 32:1255-1257, 2000
29. SUZUKI K, KAZUI T, KAWABE A, et al: Immunosuppressive effect of FTY720 on rat pancreas allograft. Transplant Proc 30:3417-3418, 1998
30. FU F, HU S, LI S, et al: FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model. Transplant Proc 33:672-673, 2000
31. MITSUSADA M, SUZUKI S, KOBAYASHI E, et al: Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Transplant Int 10:343-349, 1997
32. SUZUKI S, ENOSAWA S, KAKEFUDA T, et al: A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61:200-205, 1996
33. NIKOLOVA Z, HOF A, BAUMLIN Y, HOF RP: Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA Lewis heart and skin transplantation models. Transplant Immunol 8:267-277, 2001
34. HOSHINO Y, YANAGAWA Y, OHTSUKI M, et al: FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK506 in rat allograft models. Transplant Proc 31:224-1226, 1999
35. TAMURA A, LI XK, FUNESHIMA N, et al: Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery 127:47-54, 2000
36. YUZAWA K, STEPHKOWSKI SM, WANG M, KAHAN BD: FTYS720 blocks allograft rejection by homing of lymphocyte in vivo. Transplant Proc 32:269, 2000
37. AZUMA H, HEEMANN U, TULLIUS SG, TILNEY NL: Host leukocytes and their products in chronic kidney allograft rejection in rats. Transplant Int 7:S325-S327, 1994
38. RACUSEN LC, SOLEZ K, COLVIN RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723, 1999
39. SONG E, CHEN J, OUYANG N, et al: Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: An active mode of immune evasion in colon cancer. Br J Cancer 85:1047-1054, 2001
40. ANTUS B, YAO Y, LIU S, et al: Antiandrogens ameliorate chronic allograft nephropathy. Kidney Int 60:1955-1963, 2001
41. VIKLICKY O, ZOU H, MULLER V, et al: SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts. Transplantation 69:497-502, 2000
42. GOMEZ-MORALES M, BUSTOS M, MONTES A, et al: Influence of intrarenal deposits of ciclosporin A on acute renal transplant rejection. Nephron 70:402-409, 1995
43. VANRENTERGHEM YF: Impact of new immunosuppressive agents on late graft outcome. Kidney Int 52(Suppl 63):S81-S83, 1997
44. SUTHANTHIRAN M: Molecular analyses of human renal allografts: Differential intragraft gene expression during rejection. Kidney Int 52(Suppl 58):S15-S52, 1997
45. NADEAU KC, AZUMA H, TILNEY NL: Sequential cytokine dynamics in chronic rejection of rat renal allograft: Roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 92:8729-8733, 1995
46. YAMADA K, HATAKEYAMA E, SAKAMAKI T, et al: Involvement of platelet-derived growth factor and histocompatibility of DRB 1 in chronic renal allograft nephrophathy. Transplantation 71:936-941, 2001
47. KORCZAK-KOWALSKA G, NOWACZYK M, STEPIEN-SOPNIEWSKA B, et al: T-cell interactions with extracellular matrix proteins and endothelium in chronic renal allograft rejection. Transplant Proc 29:1057-1059, 1997
48. TAKEUCHI T, LOWRY RP, KONIECZNY B: Heart grafts in murine systems: The differential activation of Th2-like effectors in peripheral tolerance. Transplantation 53:1281-1294
49. BROMBERG JS: IL-10 immunosuppression in transplantation. Curr Opin Immunol 7:639-643, 1995
50. PINZANI M, GESUALDO L, SABBAH GM, ABBOUND HE: Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth in cultured rat liver fat-storing cells. J Clin Invest 84:1786-1793, 1989
51. BONNER JC, OSORNIO-VARGAS AR, BADGETT A, BRODY AR: Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and BB isoforms secreted by rat alveolar macrophages. Am J Respir Cell Mol Biol 5:539-549, 1991
52. SZABO A, LUTZ J, SCHLEIMER K, et al: Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int 57:982-991, 2000
53. SUZUKI S, LI XK, SHINOMIYA T, et al: Induction of lymphocyte apoptosis and üprolongation of allograft survival by FTY720. Transplant Proc 28:2049-2050, 1996
54. SUZUKI S, LI XK, ENOSAWA S, SHINOMIYA T: A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 89:518-523, 1996
55. NAGAHARA Y, IKEKITA M, SHINOMIYA T: Immunosuppressant FTY720 induces apoptosis by direct induction of üpermeability transition and release of cytochrome c from mitochondria. J Immunol 165:3250-3259, 2000
56. CHIBA K, YANAGAWA Y, MASUBUCHI Y, et al: FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 160:5037-5044, 1998
57. LUO ZJ, TANAKA T, KIMURA F, MIYAAKA M: Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology 41:199-207, 1999